Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2013 | 12-2012 | |
Sales | 793 | 0 |
Cost of Goods | 529 | N/A |
Gross Profit | 264 | N/A |
Operating Expenses | 3,943 | 0 |
Operating Income | -3,150 | N/A |
Interest Expense | 129 | 0 |
Other Income | 37 | 0 |
Pre-tax Income | -3,242 | 0 |
Net Income Continuous | -3,242 | N/A |
Net Income | $-3,242 | $N/A |
EPS Basic Total Ops | -0.55 | N/A |
EPS Basic Continuous Ops | -0.55 | N/A |
EPS Diluted Total Ops | -0.55 | N/A |
EPS Diluted Continuous Ops | -0.55 | N/A |
EBITDA(a) | $-3,066 | $N/A |